- No family history of breast cancer
- Open to hormone therapy
Options for her profile
- Hormone therapy, evaluated with her physician
- Sleep, stress and physical activity
Women's health Precision health Evidence-based care Prevention
An AI-enabled decision-support platform that helps clinicians and women's health clinics deliver personalized, holistic care in perimenopause and menopause.
The challenge
Clinicians do not all read the evidence the same way.
More than twenty years after the 2002 WHI trial, many women and physicians still hesitate to consider hormone therapy.
Most recommendations rely on drug trials.
Without decision support by profile, women try one option, then another.
Our answer
Ending trial and error
FemPrecision turns contradictory evidence into clear options. Each woman receives a personalized, evidence-based intervention that fits her, combining pharmacological and non-pharmacological care, from hormone therapy to cognitive behavioral therapy, sleep and physical activity.
Same symptoms, different women
Two women can report the same hot flashes and sleep problems, yet differ in age, stage, family history, risks and preferences.
Our AI matches each woman's profile with the strongest evidence and helps her clinician compare the options that fit her best. AI is what makes this level of personalization possible at scale.
Both reportModerate hot flashes · Sleep problems
Options for her profile
Options for her profile
Illustrative example
Changing the care journey
Clinical trials, guidelines, real-world data and complementary sources
Each woman's profile, risks, preferences and life context
Options graded by the strength of the evidence
Pharmacological and non-pharmacological, with ongoing support
Symptoms, quality of life and long-term health
Continuous learning loop: every outcome generates new evidence that improves the next personalized intervention.
What makes FemPrecision different
A decision-support platform, not a symptom tracker. The clinician decides, and uncertainties stay visible.
Our evidence engine detects contradictory information and keeps only robust clinical evidence, with its source.
Pharmacological and non-pharmacological options considered together, to anticipate perimenopause and support long-term health.
Also connecting: investors, healthcare professionals, payers and insurers, employers and industry partners.
The ecosystem we are building, to create value and better outcomes for womenPartner names will be disclosed on our upcoming website.
About FemPrecision
FemPrecision is a Swiss women's health company. Our technology builds on Swiss academic AI research, and a proof of concept is in preparation with our academic, data and clinical partners in Europe and the USA.
Our vision is to extend this approach across women's health.
Founded by Isma Hachi, PhD, with 18 years in healthcare and life sciences strategy at PwC, EY and IQVIA.
Contact
We welcome conversations with clinicians, researchers, healthcare organizations and investors who share our vision.